Press "Enter" to skip to content

Boost in Frontline Bevacizumab Use in Ovarian Cancer Linked to Guidelines Inclusion – Cancer Therapy Advisor

admin 0

Boost in Frontline Bevacizumab Use in Ovarian Cancer Linked to Guidelines Inclusion  Cancer Therapy Advisor

Addition of bevacizumab to NCCN guidelines as a frontline therapy in ovarian cancer spurred more utilization of the drug than did *fresh* findings from clinical …

“ovarian cancer” – Google News

(Visited 1 times, 1 visits today)

Leave a Reply

Your email address will not be published. Required fields are marked *